PGEN Precigen, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
18:25
Oct 21
Oct 21
r/wallstreetbets
Holding PGEN from $1.44 entry
The author reports a $100K gain on PGEN from a $1.44 entry and states the exit plan is to hold. The position is a disclosed current holding in the biotech name with no stated catalyst or risk beyond the entry price.
18:00
Jan 25
Jan 25
r/smallstreetbets
Priority review gene therapy PDUFA suggests FDA promise
PGEN has a Feb 26 PDUFA for gene therapy PRGN-3005 with priority review. The author sees priority review as suggesting FDA saw something promising, though gene therapy is boom or bust. The binary FDA decision is the catalyst.
09:20
Jan 24
Jan 24
r/biotech_stocks
Long PGEN ahead of PDUFA with 90% ML score.
The author's ML model holds PGEN long ahead of a PDUFA catalyst in 33 days, assigning a 90% confidence score for a positive catalyst outcome. A favorable FDA decision could push the stock toward the $5.03 target; the trade is invalidated below the $4.02 stop loss.
About PGEN Investor Commentary
Across the available history and selected sources, Buzzberg tracks PGEN (Precigen, Inc.) across 4 sources: 3 bullish vs 0 bearish calls from 4 authors. Historical directional balance: 43% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 7 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: u/Separate_Baker7280, u/DrinkConscious9173.